• Catheter Precision posted total revenue of USD 432,000 for the quarter ended March 31, 2026, up from USD 143,000 a year earlier, as product revenue rose 73.43% to USD 248,000 and service revenue turned positive at USD 184,000.
• Selling, general and administrative expense fell 26.57% to USD 2.56 million, while research and development expense climbed 44.66% to USD 149,000.
• Net cash used in operating activities widened to USD 2.8 million, while net cash provided by financing activities swung to USD 4.47 million.
• The quarter included about 22 days of contribution from FLYTE following the March 2026 acquisition, with the company now reporting two segments: cardiac electrophysiology and private aviation charter services.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-017509), on May 18, 2026, and is solely responsible for the information contained therein.